Brooks Laboratories Ltd

Brooks Lab. Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Brooks Laboratories Ltd

₹ 109 1.97%
26 Apr - close price
brookslabs.net BSE: 533543 NSE - BE : BROOKS
About

Incorporated in 2002, Brooks Laboratories Ltd is a pharmaceutical company working on contract basis catering to the critical care segment[1]

Key Points

Business Overview:[1]
BLL is an EU GMP & ISO 9001:2008 certified manufacturer and marketer of pharmaceutical formulations

Website BSE NSE - BE
  • Market Cap ₹ 286 Cr.
  • Current Price ₹ 109
  • High / Low ₹ 186 / 56.5
  • Stock P/E
  • Book Value ₹ 30.1
  • Dividend Yield 0.00 %
  • ROCE -27.7 %
  • ROE -23.4 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has reduced debt.
  • Company is almost debt free.

Cons

  • Stock is trading at 3.61 times its book value
  • Company has low interest coverage ratio.
  • Company's cost of borrowing seems high

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
20.92 14.62 21.70 21.46 19.01 28.46 17.12 18.08 15.30 12.61 15.70 24.32 21.75
21.57 19.12 22.07 25.74 25.39 32.37 25.72 27.30 23.85 16.31 19.61 25.42 25.12
Operating Profit -0.65 -4.50 -0.37 -4.28 -6.38 -3.91 -8.60 -9.22 -8.55 -3.70 -3.91 -1.10 -3.37
OPM % -3.11% -30.78% -1.71% -19.94% -33.56% -13.74% -50.23% -51.00% -55.88% -29.34% -24.90% -4.52% -15.49%
0.60 0.06 0.83 0.11 0.37 0.18 0.03 0.40 0.45 0.02 0.05 0.09 0.16
Interest 0.78 0.74 0.76 0.75 0.74 0.84 0.62 0.63 0.75 0.18 0.17 0.19 0.21
Depreciation 1.72 1.74 1.78 1.74 1.88 1.95 1.98 2.28 2.33 0.44 0.44 0.44 0.43
Profit before tax -2.55 -6.92 -2.08 -6.66 -8.63 -6.52 -11.17 -11.73 -11.18 -4.30 -4.47 -1.64 -3.85
Tax % 0.00% -150.00% 45.19% 27.33% 14.25% 8.90% 15.85% 32.82% 15.21% 0.00% 0.00% 0.00% -0.78%
-2.56 -17.30 -1.14 -4.83 -7.40 -5.93 -9.40 -7.87 -9.48 -4.30 -4.47 -1.64 -3.88
EPS in Rs -0.98 -6.60 -0.44 -1.84 -2.52 -1.37 -2.63 -1.79 -1.92 -1.64 -1.71 -0.62 -1.48
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2021 Mar 2022 Mar 2023 TTM
77 91 63 74
77 105 90 86
Operating Profit 1 -14 -26 -12
OPM % 1% -16% -42% -16%
1 1 -3 0
Interest 3 3 2 1
Depreciation 7 7 7 2
Profit before tax -9 -24 -38 -14
Tax % -115% 19% 19%
-19 -19 -31 -14
EPS in Rs -7.40 -4.31 -7.98 -5.45
Dividend Payout % 0% 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: %
TTM: -6%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: 30%
Stock Price CAGR
10 Years: 20%
5 Years: 20%
3 Years: 8%
1 Year: 73%
Return on Equity
10 Years: %
5 Years: %
3 Years: %
Last Year: -23%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2021 Mar 2022 Mar 2023 Sep 2023
Equity Capital 25 25 25 26
Reserves 54 63 49 53
31 25 7 4
52 83 29 23
Total Liabilities 162 196 110 106
108 110 15 14
CWIP 1 15 0 0
Investments 0 0 64 58
54 71 31 34
Total Assets 162 196 110 106

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2021 Mar 2022 Mar 2023
4 -37 -14
-5 -25 0
1 64 11
Net Cash Flow 0 2 -3

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2021 Mar 2022 Mar 2023
Debtor Days 65 71 74
Inventory Days 178 157 80
Days Payable 233 159 165
Cash Conversion Cycle 9 68 -12
Working Capital Days -5 95 -3
ROCE % -16% -28%

Shareholding Pattern

Numbers in percentages

Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
66.41% 66.41% 66.41% 66.41% 66.41% 66.41% 66.41% 66.41% 66.41% 63.59% 63.59% 63.59%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 2.46% 3.86% 3.86%
33.59% 33.59% 33.59% 33.59% 33.59% 33.58% 33.59% 33.59% 33.58% 33.94% 32.56% 32.55%
No. of Shareholders 10,42910,37910,91611,14511,10410,52410,41010,70911,21610,68610,02811,432

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Right Issue

Credit ratings